M. Weller, T. Cloughesy, and J. Perry, Standards of care for treatment of recurrent glioblastoma?are we there yet? Neurooncology, pp.4-27, 2013.
DOI : 10.1093/neuonc/nos273
URL : https://academic.oup.com/neuro-oncology/article-pdf/15/1/4/12841534/nos273.pdf

R. Stupp and F. Roila, Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up, Ann Oncol, vol.20, issue.4, pp.126-128, 2009.
DOI : 10.1093/annonc/mdn099
URL : https://academic.oup.com/annonc/article-pdf/19/suppl_2/ii83/726759/mdn099.pdf

J. Buckner, P. Brown, O. Neill, and B. , Central Nervous System Tumors, Mayo Clinic Proceedings, vol.82, issue.10, pp.1271-1286, 2007.
DOI : 10.4065/82.10.1271

X. Yuan, J. Curtin, and Y. Xiong, Isolation of cancer stem cells from adult glioblastoma multiforme, Oncogene, vol.23, issue.58, pp.9392-9400, 2004.
DOI : 10.1038/nrc866
URL : http://www.nature.com/onc/journal/v23/n58/pdf/1208311a.pdf

S. Singh, C. Hawkins, and I. Clarke, Identification of human brain tumour initiating cells, Nature, vol.64, issue.suppl. 1, pp.396-401, 2004.
DOI : 10.1158/0008-5472.CAN-04-1364

S. Bao, Q. Wu, and R. Mclendon, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.8, issue.7120, pp.756-760, 2006.
DOI : 10.1038/nn1473

E. Vauleon, T. Avril, and B. Collet, Overview of Cellular Immunotherapy for Patients with Glioblastoma, Clinical and Developmental Immunology, vol.363, issue.8, pp.1-18, 2010.
DOI : 10.1215/15228517-2009-004
URL : https://hal.archives-ouvertes.fr/inserm-00532866

V. Dutoit, C. Herold-mende, and N. Hilf, Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy, Brain, vol.171, issue.4, pp.1042-1054, 2012.
DOI : 10.4049/jimmunol.171.7.3718
URL : https://academic.oup.com/brain/article-pdf/135/4/1042/17348084/aws042.pdf

N. Bryant, G. Gillespie, and R. Lopez, Preclinical evaluation of ex vivo expanded/activated ???? T cells for immunotherapy of glioblastoma multiforme, Journal of Neuro-Oncology, vol.15, issue.Suppl 28, pp.179-188, 2011.
DOI : 10.4049/jimmunol.181.9.5857

U. Jarry, C. Chauvin, and N. Joalland, Stereotaxic administrations of allogeneic human V??9V??2 T cells efficiently control the development of human glioblastoma brain tumors, OncoImmunology, vol.28, issue.5, p.1168554, 2016.
DOI : 10.18632/oncotarget.1201

M. Lefranc and T. Rabbitts, A nomenclature to fit the organization of the human T-cell receptor ?? and ?? genes, Research in Immunology, vol.141, issue.6, pp.615-618, 1990.
DOI : 10.1016/0923-2494(90)90068-A

A. Hayday, ???? Cells: A Right Time and a Right Place for a Conserved Third Way of Protection, Annual Review of Immunology, vol.18, issue.1, pp.975-1026, 2000.
DOI : 10.1146/annurev.immunol.18.1.975

Y. Chien, C. Meyer, and M. Bonneville, T Cells: First Line of Defense and Beyond, Annual Review of Immunology, vol.32, issue.1, pp.121-155, 2014.
DOI : 10.1146/annurev-immunol-032713-120216

C. Harly, Y. Guillaume, and S. Nedellec, Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human ???? T-cell subset, Blood, vol.120, issue.11, pp.2269-2279, 2012.
DOI : 10.1182/blood-2012-05-430470
URL : http://www.bloodjournal.org/content/bloodjournal/120/11/2269.full.pdf

C. Harly, C. Peigne, and E. Scotet, Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vgamma9Vdelta2 T Cells, Front Immunol, vol.5, p.657, 2014.

A. Sandstrom, C. Peigne, and A. Leger, The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human V??9V??2??T Cells, Immunity, vol.40, issue.4, pp.490-500, 2014.
DOI : 10.1016/j.immuni.2014.03.003

J. Fournie, H. Sicard, and M. Poupot, What lessons can be learned from ???? T cell-based cancer immunotherapy trials?, Cellular & Molecular Immunology, vol.8, issue.1, pp.35-41, 2013.
DOI : 10.1038/nrclinonc.2010.223

A. Thedrez, C. Harly, and A. Morice, IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V??9V??2 T Cells for Adoptive Immunotherapy, The Journal of Immunology, vol.182, issue.6, pp.3423-3431, 2009.
DOI : 10.4049/jimmunol.0803068

A. Das, J. James, and X. Zhao, Identification of c-Kit receptor as a regulator of adult neural stem cells in the mammalian eye: interactions with Notch signaling, Developmental Biology, vol.273, issue.1, pp.87-105, 2004.
DOI : 10.1016/j.ydbio.2004.05.023

K. Oizel, C. Chauvin, and L. Oliver, Efficient mitochondrial glutamine targeting prevails over glioblastoma metabolic plasticity. clinical cancer research: an official journal of the American Association for, Cancer Res, vol.23, pp.6292-6304, 2017.
DOI : 10.1158/1078-0432.ccr-16-3102
URL : https://hal.archives-ouvertes.fr/inserm-01595798

S. Oh, J. Yang, and O. Kim, Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand, Cancer Cell International, vol.58, issue.5, p.22, 2017.
DOI : 10.1007/s00262-008-0585-3
URL : https://cancerci.biomedcentral.com/track/pdf/10.1186/s12935-017-0397-7?site=cancerci.biomedcentral.com

W. Leonard and C. Wan, IL-21 Signaling in Immunity, F1000Research, vol.5, pp.1-10, 2016.
DOI : 10.12688/f1000research.7634.1
URL : https://f1000research.com/articles/5-224/v1/pdf

R. Spolski and W. Leonard, Interleukin-21: a double-edged sword with therapeutic potential, Nature Reviews Drug Discovery, vol.119, issue.5, pp.379-395, 2014.
DOI : 10.1196/annals.1423.063

M. Allen, M. Bjerke, and H. Edlund, Origin of the U87MG glioma cell line: Good news and bad news, Science Translational Medicine, vol.74, issue.354, pp.354-353, 2016.
DOI : 10.1371/journal.pone.0008986

E. Brocard, K. Oizel, and L. Lalier, Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling, Oncotarget, vol.6, issue.9, pp.6840-6849, 2015.
DOI : 10.18632/oncotarget.3160
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=3160&path%5B%5D=6777

D. Cho, S. Lin, and W. Yang, Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme, Cell Transplantation, vol.32, issue.11, pp.731-739, 2013.
DOI : 10.1016/j.tins.2009.07.005
URL : http://journals.sagepub.com/doi/pdf/10.3727/096368912X655136

C. Barcia, . Jr, A. Gomez, and J. Gallego-sanchez, Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells, The American Journal of Pathology, vol.175, issue.2, pp.786-798, 2009.
DOI : 10.2353/ajpath.2009.081034
URL : http://europepmc.org/articles/pmc2716973?pdf=render

R. Coleman, Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer, Nature Clinical Practice Endocrinology & Metabolism, vol.19, issue.2, pp.72-73, 2009.
DOI : 10.1038/ncpendmet1045

H. Weiss, U. Pfaar, and A. Schweitzer, Biodistribution and Plasma Protein Binding of Zoledronic Acid, Drug Metabolism and Disposition, vol.36, issue.10, pp.2043-2049, 2008.
DOI : 10.1124/dmd.108.021071
URL : http://dmd.aspetjournals.org/content/dmd/36/10/2043.full.pdf

R. Spolski and W. Leonard, The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer, Current Opinion in Immunology, vol.20, issue.3, pp.295-301, 2008.
DOI : 10.1016/j.coi.2008.02.004
URL : http://europepmc.org/articles/pmc2546604?pdf=render

R. Spolski and W. Leonard, Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity, Annual Review of Immunology, vol.26, issue.1, pp.57-79, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090316
URL : https://zenodo.org/record/1234999/files/article.pdf

L. Wang, Y. Cui, and F. Ruge, Interleukin 21 and its receptor play a role in proliferation, migration and invasion of breast cancer cells, Cancer Genomics Proteomics, vol.12, pp.211-221, 2015.

A. Brenne, T. Ro, and A. Waage, Interleukin-21 is a growth and survival factor for human myeloma cells, Blood, vol.99, issue.10, pp.3756-3762, 2002.
DOI : 10.1182/blood.V99.10.3756
URL : http://www.bloodjournal.org/content/bloodjournal/99/10/3756.full.pdf

K. Skak, K. Frederiksen, and D. Lundsgaard, Interleukin-21 activates human natural killer cells and modulates their surface receptor expression, Immunology, vol.176, issue.4, pp.575-583, 2008.
DOI : 10.4049/jimmunol.176.10.6347
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2567.2007.02730.x/pdf

L. Lamb, . Jr, P. Musk, and Z. Ye, Human ????+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response, Bone Marrow Transplantation, vol.17, issue.6, pp.601-606, 2001.
DOI : 10.1002/eji.1830260223

L. Pereboeva, L. Harkins, and S. Wong, The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation, Cancer Immunology, Immunotherapy, vol.176, issue.5, pp.551-562, 2015.
DOI : 10.1667/RR2587.1